Search research articles
Contact Us
Filters
Showing results (31-40 of 95) with videos related to
Page
of 10
Sort By:
Oncology Reports
|
July 6, 2006
Dose and outcome: the hurdle of neutropenia (Review)
Maurizio Marangolo, Carmelo Bengala, Pier Franco Conte, et al.
European Journal of Clinical Investigation
|
May 22, 2021
Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review
Francesco Spagnolo, Andrea Boutros, Elena Croce, et al.
Healthcare (Basel, Switzerland)
|
August 26, 2022
The Impact of the Introduction of the Breast Unit Model in a Northwestern Italian Region
Laura Paleari, Federico Tassinari, Matteo Astengo, et al.
The Oncologist
|
December 15, 2010
Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors
Claudia Bighin, Gianluigi Lunardi, Lucia Del Mastro, et al.
International Journal of Cancer
|
February 18, 2010
Use in current clinical practice of 70-gene signature in early breast cancer
Claudia Bighin, Lucia Del Mastro, Giuseppe Canavese, et al.
Gynecologic Oncology
|
April 22, 2004
Topotecan and ifosfamide as salvage treatment in advanced ovarian cancer
Silvana Chiara, Alessandra Tognoni, Ilaria Pastrone, et al.
The Oncologist
|
May 9, 2009
Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: a meta-analytical approach
Francesco Grossi, Marianna Aita, Carlotta Defferrari, et al.
Tumori
|
June 3, 2020
Management of anemia in patients with cancer: 2019 Italian Association of Medical Oncology (AIOM) guidelines
Andrea Sbrana, Andrea Antonuzzo, Antonella Brunello, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 7, 2010
Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activity
Françoise Borcard, Matthias Baud, Claudia Bello, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 27, 2015
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial
Matteo Lambertini, Paolo Bruzzi, Francesca Poggio, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 95) with videos related to
Sort By:
Page
of 10
Oncology Reports
|
July 6, 2006
Dose and outcome: the hurdle of neutropenia (Review)
Maurizio Marangolo, Carmelo Bengala, Pier Franco Conte, et al.
European Journal of Clinical Investigation
|
May 22, 2021
Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review
Francesco Spagnolo, Andrea Boutros, Elena Croce, et al.
Healthcare (Basel, Switzerland)
|
August 26, 2022
The Impact of the Introduction of the Breast Unit Model in a Northwestern Italian Region
Laura Paleari, Federico Tassinari, Matteo Astengo, et al.
The Oncologist
|
December 15, 2010
Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors
Claudia Bighin, Gianluigi Lunardi, Lucia Del Mastro, et al.
International Journal of Cancer
|
February 18, 2010
Use in current clinical practice of 70-gene signature in early breast cancer
Claudia Bighin, Lucia Del Mastro, Giuseppe Canavese, et al.
Gynecologic Oncology
|
April 22, 2004
Topotecan and ifosfamide as salvage treatment in advanced ovarian cancer
Silvana Chiara, Alessandra Tognoni, Ilaria Pastrone, et al.
The Oncologist
|
May 9, 2009
Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: a meta-analytical approach
Francesco Grossi, Marianna Aita, Carlotta Defferrari, et al.
Tumori
|
June 3, 2020
Management of anemia in patients with cancer: 2019 Italian Association of Medical Oncology (AIOM) guidelines
Andrea Sbrana, Andrea Antonuzzo, Antonella Brunello, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 7, 2010
Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activity
Françoise Borcard, Matthias Baud, Claudia Bello, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 27, 2015
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial
Matteo Lambertini, Paolo Bruzzi, Francesca Poggio, et al.
Page
of 10